Paul Tudor Jones’s AstraZeneca AZN Stock Holding History

Paul Tudor Jones’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,800	Closed	-$2.52M	–	3549
2026 Q1	$2.52M	Buy	12,800 +8,050	+169%	+$1.55M	﹤0.01%	1679
2025 Q4	$873K	Sell	4,750 -5,450	-53%	-$956K	﹤0.01%	2361
2025 Q3	$1.57M	Sell	10,200 -8,400	-45%	-$1.27M	﹤0.01%	1967
2025 Q2	$2.6M	Buy	+18,600	New	+$2.61M	0.01%	1488
2025 Q1	–	Sell	-6,350	Closed	-$832K	–	3047
2024 Q4	$832K	Buy	6,350 +4,150	+189%	+$581K	﹤0.01%	1854
2024 Q3	$343K	Buy	+2,200	New	+$355K	﹤0.01%	2243
2024 Q1	–	Sell	-14,750	Closed	-$1.99M	–	2218
2023 Q4	$1.99M	Buy	+14,750	New	+$1.92M	0.02%	1099

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Paul Tudor Jones's AZN Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in AstraZeneca (AZN) in Q2 2026: 39,644 shares worth $7.52M. The stake represents 0.01% of the portfolio and ranks #1010 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in AZN as recently as Q3 2025.

Paul Tudor Jones first reported a position in AZN in Q2 2014 and has held it in 9 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Paul Tudor Jones held 39,644 shares of AstraZeneca worth $7.52M as of Q2 2026.
AstraZeneca was a new Paul Tudor Jones position in Q2 2026.
AstraZeneca made up 0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1010 holding.
Paul Tudor Jones first reported a position in AstraZeneca in Q2 2014 and has held it in 9 quarters since.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.